Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients
2013-01-01 Andrisani, Gianluca; Armuzzi, Alessandro; Papa, Alfredo; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; De Vitis, Italo; Rapaccini, Gian Ludovico; Guidi, Luisa
Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation
1998-01-01 Anti, M; Pignataro, G; Armuzzi, A; Valenti, A; Iascone, E; Marmo, R; Lamazza, A; Pretaroli, Ar; Pace, V; Leo, P; Castelli, A; Gasbarrini, G
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis
1998-01-01 Anti, M; Armuzzi, A; Gasbarrini, A; Gasbarrini, G
Amiodarone-induced adult respiratory distress syndrome after nonthoracotomy subcutaneous defibrillator implantation
2001-01-01 Liverani, E; Armuzzi, A; Mormile, F; Anti, M; Gasbarrini, G; Gentiloni, N
Infliximab in Crohn's disease: early and long-term treatment
2008-01-01 Armuzzi, A; De Pascalis, B; Fedeli, P; De Vincentis, F; Gasbarrini, A
Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report
2021-01-01 Pugliese, D; Schepis, T; Bove, V; Privitera, G; Boskoski, I; Armuzzi, A
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis
2019-01-01 Felice, C; Leccese, P; Scudeller, L; Lubrano, E; Cantini, F; Castiglione, F; Gionchetti, P; Orlando, A; Salvarani, C; Scarpa, R; Vecchi, M; Olivieri, I; Armuzzi, A; Italian SpA-IBD Expert Panel, Group
Etrolizumab in moderate-to-severe ulcerative colitis
2014-01-01 Armuzzi, Alessandro; Felice, C.
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: A pilot study
2001-01-01 Armuzzi, A; Cremonini, F; Ojetti, V; Bartolozzi, F; Canducci, F; Candelli, M; Santarelli, L; Cammarota, G; De Lorenzo, A; Pola, P; Gasbarrini, G; Gasbarrini, A
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study
2019-01-01 Viola, A; Pugliese, D; Renna, S; Furfaro, F; Caprioli, F; D'Incà, R; Bossa, F; Mazza, S; Costantino, G; Fantini, Mc; Fiorino, G; Alibrandi, A; Orlando, A; Armuzzi, A; Fries, W
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection
2000-01-01 Cammarota, G; Cianci, R; Cannizzaro, O; Cuoco, L; Pirozzi, G; Gasbarrini, A; Armuzzi, A; Zocco, Ma; Santarelli, L; Arancio, F; Gasbarrini, G
The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases
2019-01-01 Felice, C; Pugliese, D; Armuzzi, A
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease
2018-01-01 Laterza, L; Piscaglia, Ac; Minordi, Lm; Scoleri, I; Larosa, L; Poscia, A; Ingravalle, F; Amato, A; Alfieri, S; Armuzzi, A; Cammarota, G; Gasbarrini, A; Scaldaferri, F
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease
2022-01-01 Pugliese, D; Privitera, G; Schepis, T; Larosa, L; Onali, S; Scaldaferri, F; Gasbarrini, A; Caprioli, F; Armuzzi, A
Beneficial effects of Helicobacter pylori eradication on migraine: A 12-month follow-up study
2001-01-01 Gabrielli, M; Franceschi, F; Fiore, G; Candelli, M; Armuzzi, A; Ojetti, V; Cremonini, F; Pola, P; Giacovazzo, M; Gasbarrini, A
Anti-CagA antibodies are associated with atrophic gastritis in a population at high gastric cancer risk: a morphometric study by computerized image analysis
1997-01-01 Bonvicini, F; Baldini, L; Pretolani, S; Figura, N; Epifanio, G; Armuzzi, A; Miglio, F; Gasbarrini, G
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey
2021-01-01 Rubin, Dt; Sninsky, C; Siegmund, B; Sans, M; Hart, A; Bressler, B; Bouhnik, Y; Armuzzi, A; Afzali, A
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
2015-01-01 Pugliese, D; Guidi, L; Ferraro, Pm; Marzo, M; Felice, C; Celleno, L; Landi, R; Andrisani, G; Pizzolante, F; De Vitis, I; Papa, A; Rapaccini, Gl; Armuzzi, A
Study of liver function in healthy elderly subjects using the C-13-methacetin breath test
2003-01-01 Ciccocioppo, R; Candelli, M; Di Francesco, D; Ciocca, F; Taglieri, G; Armuzzi, A; Gasbarrini, G; Gasbarrini, A
delta(CO2)-C-13 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [C-13] urea breath test
2002-01-01 Franceschi, F; Armuzzi, A; Cremonini, F; Carloni, E; Zocco, Ma; Di Caro, S; Padalino, C; Genta, Rm; Pola, P; Gasbarrini, G; Gasbarrini, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients | 1-gen-2013 | Andrisani, Gianluca; Armuzzi, Alessandro; Papa, Alfredo; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; De Vitis, Italo; Rapaccini, Gian Ludovico; Guidi, Luisa | |
| Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation | 1-gen-1998 | Anti, M; Pignataro, G; Armuzzi, A; Valenti, A; Iascone, E; Marmo, R; Lamazza, A; Pretaroli, Ar; Pace, V; Leo, P; Castelli, A; Gasbarrini, G | |
| Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis | 1-gen-1998 | Anti, M; Armuzzi, A; Gasbarrini, A; Gasbarrini, G | |
| Amiodarone-induced adult respiratory distress syndrome after nonthoracotomy subcutaneous defibrillator implantation | 1-gen-2001 | Liverani, E; Armuzzi, A; Mormile, F; Anti, M; Gasbarrini, G; Gentiloni, N | |
| Infliximab in Crohn's disease: early and long-term treatment | 1-gen-2008 | Armuzzi, A; De Pascalis, B; Fedeli, P; De Vincentis, F; Gasbarrini, A | |
| Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report | 1-gen-2021 | Pugliese, D; Schepis, T; Bove, V; Privitera, G; Boskoski, I; Armuzzi, A | |
| Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis | 1-gen-2019 | Felice, C; Leccese, P; Scudeller, L; Lubrano, E; Cantini, F; Castiglione, F; Gionchetti, P; Orlando, A; Salvarani, C; Scarpa, R; Vecchi, M; Olivieri, I; Armuzzi, A; Italian SpA-IBD Expert Panel, Group | |
| Etrolizumab in moderate-to-severe ulcerative colitis | 1-gen-2014 | Armuzzi, Alessandro; Felice, C. | |
| Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: A pilot study | 1-gen-2001 | Armuzzi, A; Cremonini, F; Ojetti, V; Bartolozzi, F; Canducci, F; Candelli, M; Santarelli, L; Cammarota, G; De Lorenzo, A; Pola, P; Gasbarrini, G; Gasbarrini, A | |
| Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study | 1-gen-2019 | Viola, A; Pugliese, D; Renna, S; Furfaro, F; Caprioli, F; D'Incà, R; Bossa, F; Mazza, S; Costantino, G; Fantini, Mc; Fiorino, G; Alibrandi, A; Orlando, A; Armuzzi, A; Fries, W | |
| Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection | 1-gen-2000 | Cammarota, G; Cianci, R; Cannizzaro, O; Cuoco, L; Pirozzi, G; Gasbarrini, A; Armuzzi, A; Zocco, Ma; Santarelli, L; Arancio, F; Gasbarrini, G | |
| The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases | 1-gen-2019 | Felice, C; Pugliese, D; Armuzzi, A | |
| Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease | 1-gen-2018 | Laterza, L; Piscaglia, Ac; Minordi, Lm; Scoleri, I; Larosa, L; Poscia, A; Ingravalle, F; Amato, A; Alfieri, S; Armuzzi, A; Cammarota, G; Gasbarrini, A; Scaldaferri, F | |
| Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease | 1-gen-2022 | Pugliese, D; Privitera, G; Schepis, T; Larosa, L; Onali, S; Scaldaferri, F; Gasbarrini, A; Caprioli, F; Armuzzi, A | |
| Beneficial effects of Helicobacter pylori eradication on migraine: A 12-month follow-up study | 1-gen-2001 | Gabrielli, M; Franceschi, F; Fiore, G; Candelli, M; Armuzzi, A; Ojetti, V; Cremonini, F; Pola, P; Giacovazzo, M; Gasbarrini, A | |
| Anti-CagA antibodies are associated with atrophic gastritis in a population at high gastric cancer risk: a morphometric study by computerized image analysis | 1-gen-1997 | Bonvicini, F; Baldini, L; Pretolani, S; Figura, N; Epifanio, G; Armuzzi, A; Miglio, F; Gasbarrini, G | |
| International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey | 1-gen-2021 | Rubin, Dt; Sninsky, C; Siegmund, B; Sans, M; Hart, A; Bressler, B; Bouhnik, Y; Armuzzi, A; Afzali, A | |
| Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study | 1-gen-2015 | Pugliese, D; Guidi, L; Ferraro, Pm; Marzo, M; Felice, C; Celleno, L; Landi, R; Andrisani, G; Pizzolante, F; De Vitis, I; Papa, A; Rapaccini, Gl; Armuzzi, A | |
| Study of liver function in healthy elderly subjects using the C-13-methacetin breath test | 1-gen-2003 | Ciccocioppo, R; Candelli, M; Di Francesco, D; Ciocca, F; Taglieri, G; Armuzzi, A; Gasbarrini, G; Gasbarrini, A | |
| delta(CO2)-C-13 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [C-13] urea breath test | 1-gen-2002 | Franceschi, F; Armuzzi, A; Cremonini, F; Carloni, E; Zocco, Ma; Di Caro, S; Padalino, C; Genta, Rm; Pola, P; Gasbarrini, G; Gasbarrini, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891